These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28177935)

  • 21. Synthesis and characterization of a photoluminescent nanoparticle based on fullerene-silica hybridization.
    Jeong J; Cho M; Lim YT; Song NW; Chung BH
    Angew Chem Int Ed Engl; 2009; 48(29):5296-9. PubMed ID: 19533701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic nanoparticles coated with polyarabic acid demonstrate enhanced drug delivery and imaging properties for cancer theranostic applications.
    Patitsa M; Karathanou K; Kanaki Z; Tzioga L; Pippa N; Demetzos C; Verganelakis DA; Cournia Z; Klinakis A
    Sci Rep; 2017 Apr; 7(1):775. PubMed ID: 28396592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linear and Non-Linear Optical Imaging of Cancer Cells with Silicon Nanoparticles.
    Tolstik E; Osminkina LA; Akimov D; Gongalsky MB; Kudryavtsev AA; Timoshenko VY; Heintzmann R; Sivakov V; Popp J
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gold nanoparticles prepared by laser ablation in aqueous biocompatible solutions: assessment of safety and biological identity for nanomedicine applications.
    Correard F; Maximova K; Estève MA; Villard C; Roy M; Al-Kattan A; Sentis M; Gingras M; Kabashin AV; Braguer D
    Int J Nanomedicine; 2014; 9():5415-30. PubMed ID: 25473280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A High-Sensitivity and Low-Power Theranostic Nanosystem for Cell SERS Imaging and Selectively Photothermal Therapy Using Anti-EGFR-Conjugated Reduced Graphene Oxide/Mesoporous Silica/AuNPs Nanosheets.
    Chen YW; Liu TY; Chen PJ; Chang PH; Chen SY
    Small; 2016 Mar; 12(11):1458-68. PubMed ID: 26814978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging.
    He Q; Ma M; Wei C; Shi J
    Biomaterials; 2012 Jun; 33(17):4392-402. PubMed ID: 22425026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
    Hou L; Shan X; Hao L; Feng Q; Zhang Z
    Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical Monitoring of the Biodegradation of Porous and Solid Silicon Nanoparticles.
    Gongalsky MB; Pervushin NV; Maksutova DE; Tsurikova UA; Putintsev PP; Gyuppenen OD; Evstratova YV; Shalygina OA; Kopeina GS; Kudryavtsev AA; Zhivotovsky B; Osminkina LA
    Nanomaterials (Basel); 2021 Aug; 11(9):. PubMed ID: 34578485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fattigation-platform theranostic nanoparticles for cancer therapy.
    Tran TT; Tran PH; Yoon TJ; Lee BJ
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():1161-1167. PubMed ID: 28415402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells.
    Yang X; He C; Li J; Chen H; Ma Q; Sui X; Tian S; Ying M; Zhang Q; Luo Y; Zhuang Z; Liu J
    Toxicol Lett; 2014 Aug; 229(1):240-9. PubMed ID: 24831964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro cellular behaviors and toxicity assays of small-sized fluorescent silicon nanoparticles.
    Cao Z; Peng F; Hu Z; Chu B; Zhong Y; Su Y; He S; He Y
    Nanoscale; 2017 Jun; 9(22):7602-7611. PubMed ID: 28540373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Silicon Nanoparticles as Amplifiers of the Ultrasonic Effect in Sonodynamic Therapy.
    Osminkina LA; Kudryavtsev AA; Zinovyev SV; Sviridov AP; Kargina YV; Tamarov KP; Nikiforov VN; Ivanov AV; Vasilyev AN; Timoshenko VY
    Bull Exp Biol Med; 2016 Jun; 161(2):296-9. PubMed ID: 27388631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles.
    Shaterabadi Z; Nabiyouni G; Soleymani M
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():947-956. PubMed ID: 28415550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailored Dual PEGylation of Inorganic Porous Nanocarriers for Extremely Long Blood Circulation in Vivo.
    Nissinen T; Näkki S; Laakso H; Kučiauskas D; Kaupinis A; Kettunen MI; Liimatainen T; Hyvönen M; Valius M; Gröhn O; Lehto VP
    ACS Appl Mater Interfaces; 2016 Dec; 8(48):32723-32731. PubMed ID: 27934159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly luminescent and nontoxic amine-capped nanoparticles from porous silicon: synthesis and their use in biomedical imaging.
    Ahire JH; Wang Q; Coxon PR; Malhotra G; Brydson R; Chen R; Chao Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3285-92. PubMed ID: 22624976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
    Zhou Y; Han X; Jing X; Chen Y
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
    Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
    Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and characterisation of isothiocyanate functionalised silicon nanoparticles and their uptake in cultured colonic cells.
    Chao Y; Marsh AI; Behray M; Guan F; Engdahl A; Chao Y; Wang Q; Bao Y
    Faraday Discuss; 2020 Jun; 222(0):332-349. PubMed ID: 32101206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and characterization of decyl-terminated silicon nanoparticles encapsulated in lipid nanocapsules.
    Pan GH; Barras A; Boussekey L; Qu X; Addad A; Boukherroub R
    Langmuir; 2013 Oct; 29(41):12688-96. PubMed ID: 24083658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
    Thiyagarajan V; Lin SX; Lee CH; Weng CF
    Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.